tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

RMDResMed

Health care · Medical Instruments · NYSE, OTC

We are a global leader in digital health and cloud-connected medical devices. 10-K, Item 1

Employees
11,370
Headquarters
San Diego, CA
CEO
Michael J. Farrell
Next results
around Jan 28, 2027
Compare with peers → Embed

The biggest changes in the 10-K filed 2026-08-13, this fiscal year against the last, and the sentences in the MD&A (Item 7) where management explains them, quoted word for word. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Gross margin

59.4% → 61.1% (+1.7 pts) Big change FY to 2026-06-30 vs 2025-06-30

“The increase in gross margin was due primarily to procurement, manufacturing and logistics efficiencies, partially offset by expenses associated with a field safety notification for Astral devices recognized in the year ended June 30, 2026.”

Read it in the 10-K ↗

Revenue

+9.9% FY to 2026-06-30 vs 2025-06-30

“The increase in net revenue associated with our devices and masks was primarily attributable to increased demand and unit sales across our sleep health portfolio, partially offset by lower unit sales of our life support devices.”

Read it in the 10-K ↗

“The increase in net revenue associated with our devices and masks was primarily attributable to increased demand and unit sales across our sleep health portfolio, partially offset by lower unit sales of our life support devices.”

Read it in the 10-K ↗

Net income

+8.8% FY to 2026-06-30 vs 2025-06-30

“The increase in our effective tax rate for the year ended June 30, 2026 was primarily driven by the implementation of the Pillar Two global minimum tax and certain non-recurring tax benefits recognized during the year ended June 30, 2025, including the refund of interest and penalties from the IRS and tax benefits realized from the cessation of certain business activities.”

Read it in the 10-K ↗

Operating margin

32.7% → 33.4% (+0.6 pts) FY to 2026-06-30 vs 2025-06-30

“The constant currency increase in research and development expenses was primarily due to increases in employee-related costs.”

Read it in the 10-K ↗

“The constant currency increase in selling, general and administrative expenses for the year ended June 30, 2026 compared to the year ended June 30, 2025 was primarily due to increases in employee-related costs, additional expenses associated with our VirtuOx and Noctrix acquisitions, and marketing and technology investments.”

Read it in the 10-K ↗

Cash from operations

+3.1% FY to 2026-06-30 vs 2025-06-30

“The $54 million increase in cash flow from operations was primarily due to increased net income, partially offset by higher working capital during the year ended June 30, 2026 compared to the year ended June 30, 2025.”

Read it in the 10-K ↗

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K ↗

Work on RMD in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/RMD/export.csv") into a cell.